This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Progressive (PGR) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Progressive's (PGR) third-quarter premiums are likely to have benefited from solid policies in force, higher retention, competitive rates and compelling product portfolio.
Why Radian (RDN) Could Beat Earnings Estimates Again
by Zacks Equity Research
Radian (RDN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Insurance Stocks Poised to Beat Q3 Earnings Estimates
by Tanuka De
We have identified five insurers poised to outshine in the third quarter banking on solid fundamentals.
Should Value Investors Buy Radian (RDN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Marsh & McLennan Arm to Pilot Digital Placement Platform
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh subsidiary to pilot a blockchain-enabled digital platform to ease the insurance placement procedure.
Arthur J. Gallagher Acquires Consulting Firm Human Capital
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Human Capital to secure connections and expand opportunities.
Marsh & McLennan, Xevant Tie Up to Ease Employer Assistance
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Why Should You Retain CNO Financial (CNO) in Your Portfolio?
by Zacks Equity Research
Riding high on its strong revenue base and a solid capital position, CNO Financial (CNO) is expected to reap benefits for investors.
AIG Stock Hits 52-Week High: Will the Uptrend Continue?
by Zacks Equity Research
American International (AIG) stock benefits from improving operating profitability and numerous growth strategies.
Is Radian (RDN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Hold Strategy is Apt for MGIC Investment (MTG)
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow over the long term given its operational excellence and growth initiatives.
Marsh & McLennan's Unit Joins Next Peak for Cyber Protection
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Oliver Wyman teams up with Next Peak to safeguard against cyber risks.
MGIC Investment Records Solid Insurance in Force in August
by Zacks Equity Research
MGIC Investment's (MTG) August operating business statistics reflect improved insurancea in force and decline in delinquent inventory.
Here's Why You Should Invest in Radian Group (RDN) Stock Now
by Zacks Equity Research
Radian Group (RDN) is poised to grow over the long term given its operational excellence and growth initiatives.
Marsh & McLennan Inks Deal With Construction Risk Partners
by Zacks Equity Research
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Is Radian (RDN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife's Rising Revenues & Streamlining Measures Aid Growth
by Zacks Equity Research
MetLife (MET) benefits from business streamlining, strong capital position and revenue growth.
AIG Up 33% This Year After Dismal Run in 2018: What's Ahead?
by Sapna Bagaria
Acquisitions, dispositions, cost management, reinsurance strategies and other growth initiatives are aiding AIG's stock.
Old Republic Rewards Shareholders, Okays Special Dividend
by Zacks Equity Research
Special dividend approval by the board of directors of Old Republic International (ORI) marks the company's decision to return excess capital to its shareholders.
Why Hold Strategy is Apt for Cboe Global (CBOE) Stock Now
by Zacks Equity Research
Cboe Global (CBOE) is poised to grow on strong market position, global reach and strength in its proprietary products.
eHealth (EHTH) Rallies 165% YTD: Will the Upside Continue?
by Zacks Equity Research
eHealth's (EHTH) operational excellence and growth initiatives help the stock continue the bull run.
W.R. Berkley (WRB) Rises 46% YTD: Will the Rally Continue?
by Zacks Equity Research
W.R. Berkley's (WRB) operational excellence and growth initiatives help the stock continue the bull run.
Assurant Surges 37% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Assurant's (AIZ) operational excellence and growth initiatives help the stock continue the bull run.
Radian Group (RDN) Okays Share Buyback Program Worth $200M
by Zacks Equity Research
Radian Group's (RDN) new share repurchase program reflects effective capital deployment backed by solid financial position banking on strong core operations.